Upgrade to SI Premium - Free Trial

Imperial Capital Reiterates Outperform on Imperva (IMPV) Following 2Q Preliminary Results

July 13, 2016 7:10 AM
Imperial Capital reiterated an Outperform rating and $55.00 price target on Imperva (NYSE: IMPV) following the company's 2Q preliminary results ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles